AXGN Axogen, Inc.
AXGN Axogen, Inc.
Healthcare · Medical Devices
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $32.28 · VWAP $37.19 · -6.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster EVP, Director + 1 other sold $4.5M, Aug 11–12
Coverage
1 watchlist
AXGN Price Structure
Loading timeframes…
Peers
Every watchlist AXGN belongs to, members best 30-day change first — AXGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: revenue $70M, diluted EPS -$0.03, net income -$2M (SEC filing). Across the print the stock moved +0.5% (close before → first close after).
full note →Against street estimates
How AXGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about AXGN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 17
- Press Releases :: Axogen, Inc. (AXGN)
- Axogen (AXGN) Stock Price History 2011-2026
- Axogen, Inc. (AXGN)
- Axogen, Inc. 8-K exhibit 99.1: EX-99.1 PRESS RELEASE, filed October 1, 2026
- Axogen, Inc. 8-K filed September 10, 2026
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
AXGN research tape
69 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.